Biostatistics Advance Access originally published online on December 6, 2005
Biostatistics 2006 7(2):167-181; doi:10.1093/biostatistics/kxj009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A tail strength measure for assessing the overall univariate significance in a dataset
Department of Statistics, Stanford University, Stanford, CA 94305,USA jtaylor{at}stat.stanford.edu
Department of Health Research and Policy and Department of Statistics, Stanford University, Stanford, CA 94305, USA tibs{at}stanford.edu
* To whom correspondence should be addressed.
We propose an overall measure of significance for a set of hypothesis tests. The tail strength is a simple function of the p-values computed for each of the tests. This measure is useful, for example, in assessing the overall univariate strength of a large set of features in microarray and other genomic and biomedical studies. It also has a simple relationship to the false discovery rate of the collection of tests. We derive the asymptotic distribution of the tail strength measure, and illustrate its use on a number of real datasets.
Keywords: Multiple testing; p-value
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. L. Goode, M. J. Maurer, T. A. Sellers, C. M. Phelan, K. R. Kalli, B. L. Fridley, R. A. Vierkant, S. M. Armasu, K. L. White, G. L. Keeney, et al. Inherited Determinants of Ovarian Cancer Survival Clin. Cancer Res., February 1, 2010; 16(3): 995 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Cerhan, W. Liu-Mares, Z. S. Fredericksen, A. J. Novak, J. M. Cunningham, N. E. Kay, A. Dogan, M. Liebow, A. H. Wang, T. G. Call, et al. Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor-{kappa}B Canonical Pathway and Risk of Non-Hodgkin's Lymphoma Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3161 - 3169. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Rimsza, M. L. LeBlanc, J. M. Unger, T. P. Miller, T. M. Grogan, D. O. Persky, R. R. Martel, C. M. Sabalos, B. Seligmann, R. M. Braziel, et al. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP Blood, October 15, 2008; 112(8): 3425 - 3433. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Habermann, S. S. Wang, M. J. Maurer, L. M. Morton, C. F. Lynch, S. M. Ansell, P. Hartge, R. K. Severson, N. Rothman, S. Davis, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era Blood, October 1, 2008; 112(7): 2694 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Cerhan, S. M. Ansell, Z. S. Fredericksen, N. E. Kay, M. Liebow, T. G. Call, A. Dogan, J. M. Cunningham, A. H. Wang, W. Liu-Mares, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma Blood, December 15, 2007; 110(13): 4455 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Cerhan, S. Wang, M. J. Maurer, S. M. Ansell, S. M. Geyer, W. Cozen, L. M. Morton, S. Davis, R. K. Severson, N. Rothman, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival Blood, June 15, 2007; 109(12): 5439 - 5446. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Schork, T. A. Greenwood, and D. L. Braff Statistical Genetics Concepts and Approaches in Schizophrenia and Related Neuropsychiatric Research Schizophr Bull, January 1, 2007; 33(1): 95 - 104. [Abstract] [Full Text] [PDF] |
||||



